Is ANAB or INBX more profitable?

ANAB runs the higher net margin — ANAB at 82.37% versus INBX at -10773.46%.

How have ANAB and INBX total returns compared?

Over the past 5 years, ANAB delivered 21.54% and INBX delivered 27.64% annualized total return. Past performance doesn't predict future results.

AnaptysBio, Inc. (ANAB) vs Inhibrx Biosciences Inc. (INBX)

A side-by-side comparison of AnaptysBio, Inc. and Inhibrx Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANAB

AnaptysBio, Inc.

$1.43B

$48.19HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT

INBX

Inhibrx Biosciences Inc.

$1.40B

$95.48HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT

Total return — ANAB vs INBX

growth of $100 · dividends reinvested · last 6y

ANAB +316.9% (+26.9%/yr)INBX +382.3% (+30.0%/yr)INBX compounded faster over this window

ANAB INBX

ANAB vs INBX: by the numbers

•ANAB is the larger company ($1.43B vs $1.40B market cap).
•ANAB is profitable (82.37% net margin) while INBX runs a net loss (-10773.46%).

Metrics side by side

Valuation

Metric	ANAB	INBX
P/E ratio	8.97	N/A
P/S ratio	6.00	N/A
P/B ratio	134.80	N/A
EV / EBITDA	11.51	N/A
FCF yield	1.26%	N/A

Profitability

Metric	ANAB	INBX
Gross margin	98.97%	-91.00%
Operating margin	20.42%	-10386.54%
Net margin	82.37%	-10773.46%
ROE	1849.06%	N/A
ROIC	47.55%	-99.35%

Growth (annualized)

Metric	ANAB	INBX
Revenue CAGR (5Y)	18.60%	N/A
FCF CAGR (5Y)	27.41%	N/A
Total return CAGR (5Y)	21.54%	27.64%

Frequently asked

Is ANAB or INBX more profitable?: ANAB runs the higher net margin — ANAB at 82.37% versus INBX at -10773.46%.
How have ANAB and INBX total returns compared?: Over the past 5 years, ANAB delivered 21.54% and INBX delivered 27.64% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANAB analysis Full INBX analysis Interactive comparison tool

Dig into the metrics

AnaptysBio P/E ratio AnaptysBio ROE Inhibrx Biosciences ROE AnaptysBio operating margin Inhibrx Biosciences operating margin AnaptysBio revenue growth Inhibrx Biosciences revenue growth AnaptysBio free cash flow Inhibrx Biosciences free cash flow

AnaptysBio & Inhibrx Biosciences appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.